Abstract
The first example of mitochondrial delivery of the anticancer drug doxorubicin (Dox) is presented by lipid-functionalized DNA nanocages (LNCs). Dox localized in mitochondria induces significant cytotoxicity and cellular apoptosis in MCF-7 compared with Dox localized in lysosomes. These results suggest that LNC has the potential to be an outstanding tool in the treatment of specific organelle-related diseases such as cancers. Delivery of the anticancer drug doxorubicin to mitochondria by lipid-functionalized DNA nanocages (LNCs) is demonstrated for the first time. The results suggest outstanding potential for the use of LNCs as drug nanocarriers in treatments for organelle-specific diseases.
Original language | English |
---|---|
Pages (from-to) | 770-781 |
Number of pages | 12 |
Journal | Small |
Volume | 12 |
Issue number | 6 |
DOIs | |
Publication status | Published - 10 Feb 2016 |
Scopus Subject Areas
- Biotechnology
- Biomaterials
- Chemistry(all)
- Materials Science(all)
User-Defined Keywords
- anticancer drugs
- delivery
- DNA nanocarriers
- lipophilic molecules
- mitochondria